Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the effectivity of intranasal dexmedetomidine
sedation during intra-articular injection therapy. Intranasal dexmedetomidine is compared
with dinitrous oxide (N2O) which has already been proven safe and effective sedation method
during painful procedures in pediatric patients.
In earlier studies the median VAS during intra-articular corticosteroid injections with
patients receiving nitrous oxide has been 3 (Uziel et al 2008). Study hypothesis is that with
intranasal dexmedetomidine sedation the VAS pain levels will be 1 unit lower.
Phase:
Phase 4
Details
Lead Sponsor:
University of Oulu
Treatments:
Dexmedetomidine Hypnotics and Sedatives Nitrous Oxide